The Italian Pharmacovigilance Program: An Observational Study of Adverse Effects of Natalizumab in Multiple Sclerosis Therapy Giacoppo S, Ruscica M, Grimaldi LM, Bramanti P, Mazzon E Medical Science Monitor – September 2017 Background: This study shows…
Read moreProlonged Cerebrospinal Fluid Neurofilament Light Chain Increase in Patients with Post-Traumatic Disorders of Consciousness Bagnato S, Grimaldi LME, Di Raimondo G, Sant’Angelo A, Boccagni C, Virgilio V and Andriolo M Journal of Neurotrauma – August…
Read moreMultiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromes Martinelli V, Dalla Costa G, Messina MJ, Di Maggio G, Sangalli F, Moiola L, Rodegher M, Colombo B, Furlan R, Leocani L, Falini A, Comi G. Acta Neurologica Scandinavica…
Read moreThe MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature. Jarius S, Eichhorn P, Franciotta D, Petereit HF, Akman-Demir G, Wick M, Wildemann B. Journal of Neurology – March 2017 Abstract Background:…
Read more
